ESR1 and breast carcinoma: We have presented a communication model to quantify signal fidelity and error rates based on digital communication theory and shown that immune cells in the peripheral blood of ER+ breast cancer patients exhibit increased ligand identification error rates and reduced signal fidelity as compared to healthy controls.